Cargando…
Precision Medicine with TGF-β Inhibition Using Tumor Explants: Comment on “Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor” by N. Sumru Bayin et al.
In a new report, Bayin et al. described an ex vivo explant model to test the patient-specific response to transforming growth factor-β inhibition in high-grade gliomas.
Autores principales: | Huang, Haidong, Yu, Jennifer S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156519/ https://www.ncbi.nlm.nih.gov/pubmed/27978995 http://dx.doi.org/10.1016/j.neo.2016.10.009 |
Ejemplares similares
-
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor()()
por: Bayin, N. Sumru, et al.
Publicado: (2016) -
Glutathione and catalase suppress TGFβ-induced cataract-related changes in cultured rat lenses and lens epithelial explants
por: Chamberlain, Coral G., et al.
Publicado: (2009) -
Cytotoxicity of β-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations
por: Prajapati, Manisha, et al.
Publicado: (2021) -
TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway
por: Yang, Tian, et al.
Publicado: (2019) -
The ethics of explantation
por: Hansson, Sven Ove
Publicado: (2021)